Most Recent
The NSW Court of Appeal has struck down a law passed in the wake of the Bondi massacre that barred protest after a terrorist incident, finding it unconstitutional.
Construction PRO
Mining magnate Gina Rinehart is on the hook for royalties payable to the heirs of iron ore pioneers Don Rhodes and Peter Wright, a judge has held in a long-running battle over lucrative tenements in the Pilbara region.
Australia's richest person Gina Rinehart could be on the hook for millions of dollars in royalty payments, in a long-running battle over lucrative iron ore mining tenements in Western Australia's Pilbara region.
US-based drug maker Cosette has lost its bid to stay proceedings alleging it induced the treasurer to reject its $672 million tie-up with Mayne Pharma, with a judge finding Mayne has a right to prosecute its case and would be prejudiced by the delay.
A judge has refused to disqualify himself from case managing Mayne Pharma's latest dispute with US drug maker Cosette over the collapse of their $672 million merger agreement, calling the bid “plainly premature”.
Collapsed supply chain finance company Greensill Bank can't access a copy of a Tokio Marine unit's database, with a judge finding the copy was created for the primary purpose of HWL Ebsworth providing legal advice.
A SkyCity shareholder has lost his bid to bring a case against former executives and directors at the ASX-listed casino seeking to recoup a $67 million penalty over breaches of money laundering regulations.
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
London City Equities has reached a settlement with listed firm Excelsior in a case alleging shareholder oppression over a decision to sell off a subsidiary for $101 million and not distribute the proceeds.
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.